Souzan B. Yanni

发表

9. Translational Tools toward Better Drug Therapy in Human Populations

Souzan B. Yanni, 2015 .

Distribution: Principle, Methods, and Applications

Souzan B. Yanni, 2015 .

Drug Metabolism and Interactions in Pediatric Patients

K. Allegaert, Souzan B. Yanni, 2012 .

In Vitro Investigation of the Hepatobiliary Disposition Mechanisms of the Antifungal Agent Micafungin in Humans and Rats

K. Brouwer, D. Benjamin, P. Annaert, 2010, Drug Metabolism and Disposition.

Microsoft Word-46723493-file00

K. Brouwer, P. Annaert, Souzan B. Yanni, 2010 .

Modulation of the Tight Junctions of the Caco-2 Cell Monolayers by H2-antagonists

D. Thakker, L. Gan, Dhiren R. Thakker, 2004, Pharmaceutical Research.

Role of Flavin-Containing Monooxygenase in Oxidative Metabolism of Voriconazole by Human Liver Microsomes

D. Benjamin, P. Annaert, P. Augustijns, 2008, Drug Metabolism and Disposition.

6. General Toxicology: Principle, Methods, and Applications

Souzan B. Yanni, 2015 .

Fexofenadine Brain Exposure and the Influence of Blood-Brain Barrier P- glycoprotein Following Fexofenadine and Terfenadine Administration

G. M. Pollack, J. C. Kalvass, Rong Zhao, 2008 .

Microsoft Word-56232673-file00

J. C. Kalvass, Rong Zhao, Gary M. Pollack, 2008 .

Higher clearance of micafungin in neonates compared with adults: role of age‐dependent micafungin serum binding

P. Smith, D. Benjamin, P. Annaert, 2011, Biopharmaceutics & drug disposition.

In Vitro Hepatic Metabolism Explains Higher Clearance of Voriconazole in Children versus Adults: Role of CYP2C19 and Flavin-Containing Monooxygenase 3

J. Ibrahim, D. Benjamin, P. Annaert, 2010, Drug Metabolism and Disposition.

Toxicokinetics and Toxicity Testing in Drug Development1

Souzan B. Yanni, 2015 .

Prodrugs: Absorption, Distribution, Metabolism, Excretion (ADME) Issues

D. Thakker, Souzan B. Yanni, 2007 .

Translational Concept and Determination of Drug Absorption

Souzan B. Yanni, 2015 .

Excretion: Principle, Methods, and Applications for Better Therapy

Souzan B. Yanni, 2015 .

USE OF CACO-2 CELLS AS AN IN VITRO INTESTINAL ABSORPTION AND METABOLISM MODEL

D. Thakker, L. Gan, P. Hsyu, 1994 .

Drug–Drug Interaction: From Bench to Drug Label

Souzan B. Yanni, 2015 .

3. Metabolism: Principle, Methods, and Applications

Souzan B. Yanni, 2015 .

Translational ADMET for Drug Therapy: Principles, Methods, and Pharmaceutical Applications

Souzan B. Yanni, 2015 .

Fexofenadine Brain Exposure and the Influence of Blood-Brain Barrier P-Glycoprotein After Fexofenadine and Terfenadine Administration

Gary M Pollack, J. C. Kalvass, Rong Zhao, 2009, Drug Metabolism and Disposition.

10. Phase 1–Phase 3 Clinical Studies, Procedures, Responsibilities, and Documentation

Souzan B. Yanni, 2015 .

Regulatory Submission: MIST and Drug Safety Assessment

Souzan B. Yanni, 2015 .

PBPK Modeling and In Silico Prediction for ADME and Drug–Drug Interaction

Souzan B. Yanni, 2015 .